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Abstract
Background: Sub-Saharan Africa has a great burden of critical illness with limited health care resources. We evaluated
the feasibility and utility of the modified Sequential Organ Function Assessment (mSOFA) score in assessing morbidity
and mortality in the National Referral Hospital’s intensive care unit (ICU) for one year.
Methods: We conducted a prospective, observational cohort study on patients above 12 years of age admitted to the
ICU at Mulago Hospital (Kampala, Uganda). All SOFA scores were determined at admission and at 48 h. We modified
the SOFA score by replacing the PaO2/FiO2 ratio with SPO2/FiO2. The primary outcome was ICU mortality.
Results: This ICU cohort of 118 patients had a mean age of 37 years and an ICU mortality rate of 46.6%. Non-survivors
had higher initial (7.7 SD 3.8 vs. 5.5 SD 3.3; p = 0.007), mean (8.1 SD 3.9 vs 4.7 SD 2.6; p < 0.001) and highest mSOFA
scores (9.4 SD 4.2 vs. 5.8 SD 3.2; p < 0.001), with an increase of 1.0 (SD 3.1) mSOFA on average after 48 h when
compared to survivors (p < 0.001). The area under the receiver operating characteristic curves for each mSOFA
category was: initial-0.68, mean-0.76, highest-0.76 and delta mSOFA-0.74. Multivariate logistic regression analysis
showed no significant association between mSOFA scores and mortality.
Conclusion: Our results confirm that calculation of the mSOFA score is feasible for an ICU population in a
resource-limited country. More data are needed to test for an association between mSOFA and mortality.
Keywords: Modified sequential organ function assessment, Mortality, Low and middle-income countries,
Illness severity scoring system, Critical care
Background
Critical illness in low and middle income countries
(LMICs) is a major component of the global burden of
disease [1]. These countries have relatively younger
patient populations than those of high income countries
(HICs) [2, 3]. Despite this, ICU patients in LMICs still
have more morbidity and mortality than those in HICs
largely due to limited resources and the severity of
co-morbid conditions [1–4].
In 1994, the European Society of Intensive Care
Medicine (ESICM) committee developed the Sequen-
tial Organ Failure Assessment (SOFA) score 5, 6]. This
score assesses the functionality of six organ systems
(Table 1) [7]. It was validated as a tool for assessment
of organ dysfunction and mortality prediction in ICU
[8]. While simpler than many other tools used to pre-
dict ICU mortality, the application of SOFA still re-
quires several lab tests (platelets, bilirubin, creatinine
and blood gas analysis) [6, 8, 9]. The availability of
such lab tests in LMICs is limited thereby limiting the
widespread applicability of this score [1]. Some studies
have validated modifications of the SOFA score in
which certain lab tests were replaced with more readily
* Correspondence: cornels77@gmail.com
1Department of Anesthesia and critical care,, Makerere University College of
Health Sciences, P.O. Box 7072, Kampala, Uganda
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sendagire et al. BMC Anesthesiology  (2017) 17:12 
DOI 10.1186/s12871-017-0304-8
available clinical measurements [10–12]. The SOFA
score, for example, requires blood gas analysis for
calculating the PaO2/FiO2 ratio [5]. However, a study
in a HIC validated the use of SpO2/FiO2 ratio as a sur-
rogate for the PaO2/FiO2 [10]. This modification was
hypothesized to increase feasibility in settings where
blood gas measurements are not regularly available.
However, this modified SOFA score has not been vali-
dated in LMICs. In another study in a HIC, a modified
SOFA score requiring only one laboratory measure-
ment was validated to assess feasibility for critical care
triage during pandemics [11]. In that study, Grissom et
al. eliminated platelet count, substituted SpO2 for
PaO2, replaced bilirubin with icterus and did bedside
point-of-care creatinine testing. The only study to date
from a low-income country was conducted in an urban
hospital in Nepal and validated the use of the SOFA
score but without any modification [12].
Due to low specificity of the SIRS criteria, the most
recent sepsis guidelines have incorporated SOFA score
into the new sepsis definition [13, 14]. Unlike SIRS cri-
teria however, the SOFA requires more laboratory eval-
uations which limit its feasibility in LMICs [9].
With a paucity of literature aimed at addressing crit-
ical care in LMICs, we conducted a study to determine
the feasibility and utility of using a modified SOFA
(mSOFA) Score for assessing organ dysfunction and
predicting mortality in a tertiary hospital ICU of a low-
income country.
Methods
Study area and setting
We conducted a prospective, observational cohort study
for one year (February, 2014 – January, 2015) in the ICU
of Mulago Hospital (Kampala, Uganda). Mulago Hospital
is a 1500-bed teaching hospital and the national referral
hospital for Uganda. The hospital’s inpatient census often
exceeds 2000 and has a large proportion of critically-ill
patients [15]/ The hospital’s ICU has eight beds although
only four beds are equipped with ventilators. The ICU is
staffed by two intensivists, one senior resident, one to two
anesthesia residents per day, and nurses. It has a nurse to
patient ratio of 1:2 – 1:4. Complete blood counts, as well
as liver and renal function tests are routinely available;
however, blood gas analysis is rarely available. The ICU
admits between 200–300 critically-ill patients annually
with an ICU mortality of approximately 40% [16].
Study population
Study approval was granted by the Makerere University
School of Medicine Research and Ethics Committee. A
written informed consent/assent was obtained from
next of kin prior to enrollment or a waiver of consent
was obtained for those without next of kin. All patients
>12 years of age admitted to the Mulago Hospital ICU
for more than 24 h were enrolled. We chose a lower
limit of 13 years because the SOFA score has not been
validated among patients <13 years [5]. The exclusion
criteria were admission for low risk monitoring, death
Table 1 Sequential Organ Function Assessment score
SOFA score 0 1 2 3 4
Respiratory
PaO2/FiO2 >400 300–400 200–300 100–200 <100
SPO2/FIO2
a >301 221–301 142–220 67–141 <67
Coagulation
Platelets 103/mm3 >150 <150 <100 <50 <20
Liver
Bilirubin (mg/dL) <1.2 1.2–1.9 2.0–5.9 6.0–11.9 >12.0
Cardiovascular
Hypotension No MAP Dopamine Dopamine Dopamine
hypotension <70 </=5ug/kg/min or
dobutamine (any dose)
>5ug/kg/min or norepinephrine
</=0.1ug/kg/min
>15ug/kg/min or
norepinephrine >0.1ug/kg/min
CNS
Glasgow Coma 15 13–14 10–12 6–9 <6
Score
Renal
Creatinine (mg/dL)/urine
output (ml/d)
<1.2 1.2–1.9 2.0–3.4 3.5–4.9 or <500 >5.0 or <200
SPO2: Peripheral saturation of oxygen; FiO2: Fraction of inspired Oxygen; MAP: Mean Arterial Pressure; CNS; Central Nervous System
aModification to include SPO2/FIO2 as a replacement for PaO2/FiO2
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or discharge in the first 24 h and no outcome at the
end of the study.
Study procedure
We collected demographic data, all vital signs, complete
blood count, as well as liver and renal function tests for
each patient at admission and at 48 h after admission.
Blood gas analysis was to be done with the ABL 80 Flex
model in the ICU. The mSOFA score, ranging from 0
(normal organ function) to 24 (worst organ dysfunction),
was calculated on admission (T0) and at 48 h (T48). Pa-
tients were then followed until ICU discharge or the end
of the study period. In calculating the mSOFA score, the
worst values for each parameter in the 24-h period were
used. The SPO2/FiO2 ratio was used instead of PaO2/FiO2
ratio, and the remaining parameters were used based on
the calibration as shown in Table 1. We selected the range
cutoffs shown in Table 1 as these ranges had been vali-
dated in two prior studies. For patients on nasal cannula
oxygen, we estimated FiO2 by multiplying the liter flow
per minute by 0.03 and adding that to 0.21. For a single
missing data point, a replacement was estimated by calcu-
lating the mean of the sum of the results immediately pre-
ceding and following the missing value. The total mSOFA
score was calculated as the sum of the mSOFA score at
admission and at 48-h. The initial mSOFA score was the
average T0 of all patients. The mean mSOFA score was
defined as the average of mSOFA score over the two days
of calculation of the mSOFA while in the ICU. The high-
est recorded SOFA score was also recorded as the highest
between the two recording times. The delta SOFA score
was defined as the difference between T0 and T48. After
discharge or death, data were crosschecked for complete-
ness and accuracy with patient’s chart prior to data entry
by a trained staff member.
Statistical analysis
The primary outcome was ICU mortality or discharge.
We compared continuous variables of the survivors and
non-survivors using the student t-test with a significant
p-value of <0.05. We used the chi-square test for cat-
egorical variables with a significant p-value of <0.05.
Odd ratios with 95% confidence interval were computed
using a multivariate logistic regression model with ICU
mortality as the dependent variable. The predictive ability
of the SOFA scores was evaluated using receiver operating
characteristic (ROC) curve analysis generated on STATA
12 (Statacorp College Station, TX). The area under the re-
ceiver operating characteristic curve (AUROC) was used to
compare the discriminatory power of the scoring system,
with an AUC 1.0 considered perfect discrimination and 0.5
considered equal to chance. Numerical continuous data
were summarized as means, standard deviations for the
normally distributed data, and as medians and interquartile
ranges for the non-normally distributed data. Categorical
data were summarized with percentages and proportions.
Results
From February 20, 2014 to January 31, 2015 we screened
201 patients, and enrolled 170. Subsequently, 51 patients
were excluded. Of these, 42 of them were admitted for
only 24-h of postoperative monitoring, nine died within
24 h of admission and only one had no outcome at the
end of the study (Fig. 1). There were nine non-adults
Fig. 1 Enrolment
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(ages 13–18) in the cohort, all of whom had informed
consent obtained from their appropriate family mem-
bers. We thus analyzed 118 patients (58% male) with a
mean (SD) age of 37 (17) years and an ICU mortality
rate of 46.6%. During the study period, PaO2 values
were missing in 90% of the study patients while there
was no missing value for bilirubin, creatinine and plate-
let count. The median length of stay in the ICU was six
days (IQR; 3–10) while the median survival time within
the ICU was 12 days (95% CI 6.38–17.62). Sepsis preva-
lence according to the SIRS criteria was 50% on admis-
sion to the ICU. Table 2 summarizes the demographics
and initial clinical characteristics of the study cohort.
The initial, mean, highest and delta mSOFA scores
(SD) were: 6.5 (3.7), 6.3 (3.7), 7.5 (4.1) and 0.4 (3.2) re-
spectively. Non-survivors had significantly higher initial,
mean and higher mSOFA scores than survivors: 7.7 vs.
5.5 (p = 0.001), 8.1 vs. 4.7 (p < 0.001) and 9.4 vs. 5.8
(p < 0.001) respectively. We also found that while the
initial mSOFA score decreased by 1.7 in survivors; that
of non-survivors increased by 1.0 after 48 h (p < 0.001).
On admission, only the respiratory and cardiovascular
mSOFA scores of non-survivors were significantly
higher than those of survivors (Table 3). The same trend
was observed at 48 h, however, the central nervous system
and renal mSOFA scores were also significantly higher
in non-survivors.
The adjusted odds ratios of the mSOFA scores for
mortality were not statistically significant despite trends
showing direct proportionality with mortality as seen in
Fig. 2 and neither was there a statistical difference in their
slopes found. The 48-h change in mSOFA score also had
no significant association with mortality p-value = 0.61.
Using AUROC for discriminating mortality, the initial
mSOFA score had the lowest predictive power with an
AUC of 0.68 (95% CI, 0.58-0.77) while the mSOFA at
48 h had the highest predictive power of 0.79 (95% CI,
0.71–0.87). The mean, highest and delta mSOFA scores
demonstrated a fairly accurate prediction with AUROC:
0.76 (95% CI, 0.68–0.85), 0.76 (95% CI, 0.66–0.85), and
0.74 (95% CI, 0.65–0.84) respectively (Fig. 3 and Table 4).
We also found that the mean mSOFA score AUC was
significantly higher than that of the initial mSOFA with
a p value of 0.0003.
Table 2 Demographics and clinical characteristics of 118 critically patients admitted to mulago hospital icu from February 2014
to January 2015
Characteristics All Survivors Non-Survivors Pa
Age (years); mean (SD) 37.7 (17.5) 37.7 (17.4) 37.7 (17.7) 0.99
Sex
Male (%) 68 (57.6) 41 (66.7) 25 (47.3) 0.033
Source (%)
Emergency room 33 (28) 19 (30.2) 14 (25.4)
Operating room 21 (17.8) 15 (23.8) 6 (10.9)
PACU 2 (1.7) 2 (3.2) 0 (0.0)
Obstetric theatre 3 (2.5) 0 (0.00) 3 (5.5)
Medical ward 25 (21.2) 9 (15.9) 15 (27.3)
Surgical ward 11 (9.3) 6 (9.5) 5 (9.1)
Obstetric-gynecology ward 7 (5.9) 2 (3.2) 5 (9.1)
Other hospital 16 (13.6) 9 (14.3) 8 (12.7) 0.117
Medical Admissions (%) 40 (33.9) 20 (31.8) 20 (36.4) 0.597
HIV status (%)
Positive 12 (10.1) 6 (9.5) 6 (10.8)
Negative 88 (74.6) 48 (77.8) 41 (73.6)
Unknown 18 (15.3) 8 (12.7) 9 (16.2) 0.664
Mechanical Ventilation (%) 100 (84.8) 47 (47.0) 53 (53.0) 0.001
Ventilation time (SD) (hours) 159.07 (247.87) 156.05 (227.95) 162.53 (270.99) 0.888
Vasopressor use (%) 28 (23.7) 4 (14.2) 24 (85.7) 0.008
Length of stay (Days);mean (SD) 10.2 (12.8) 12.5 (13.8) 7.5 (11.1) 0.033
No. of patients (%) 118 63 (53.4) 55 (46.6)
PACU: Post anaesthetic care unit; SD: Standard deviation; HIV: Human immunodeficiency virus; ICU: Intensive care unit; ABG: Arterial blood gas
Pa values calculated using unpaired t tests, Mann–Whitney U tests, or chi-square tests where appropriate
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Discussion
The present study is the first in Sub-Saharan Africa to
determine the feasibility and utility of modifying the
SOFA score for evaluating organ dysfunction and critical
care mortality in a resource-limited ICU. In our study
we were able to calculate mSOFA for all patients even
though we were unable to prove that it is a good
predictor of mortality. Since 90% were missing PaO2
values; majority of patients in our study did not have
data required to calculate a traditional SOFA score.
The use of simple, inexpensive and rapid methods to
assess illness severity and predict outcomes is important
in all clinical settings, especially those in low-income
countries where resources are limited and illness severity
is high [1, 4, 6, 11]. Recently the specificity of SIRS cri-
teria for sepsis has come into question and led to the
development of new sepsis definitions that now include
the SOFA score [13, 14, 17, 18]. Although the Third
Consensus Definitions for Sepsis and Septic Shock in-
cludes a discussion of quick SOFA (qSOFA) scores, the
vast majority of efforts to simplify or validate scoring
tools (like SOFA) take place almost exclusively in high-
income countries.
The initial mSOFA score for our study was less than
that of a study from HIC and the only other study from
a LIC; Nepal (6.5 vs. 7.1 vs. 7.9 respectively) [7, 12]. The
Table 3 Calculated sofa scores and comparisons of 118 critically
ill-patients admitted to mulago hospital icu from February 2014
to January 2015
SOFA score All Survivors Non-survivors Pa
SOFA-0 mean (SD)
SOFA-RS 1.6 (1.2) 1.3 (1.2) 1.9 (1.2) 0.007
SOFA-CVS 0.6 (1.2) 0.2 (0.7) 1 (1.6) 0.001
SOFA-CNS 2.8 (1.1) 2.8 (1.2) 2.8 (1.1) 0.66
SOFA-Liver 0.3 (0.8) 0.2 (0.7) 0.4 (0.8) 0.168
SOFA-coagulation 0.3 (0.7) 0.3 (0.6) 0.4 (0.7) 0.364
SOFA-renal 1 (1.5) 0.8 (1.4) 1.2 (1.6) 0.115
Total SOFA 6.5 (3.7) 5.5 (3.3) 7.7 (3.8) 0.001
SOFA-48 mean (SD)
SOFA-RS 1.2 (1.2) 0.7 (0.9) 1.8 (1.4) <0.001
SOFA-CVS 0.7 (1.4) 0.1 (0.4) 1.4 (1.8) <0.001
SOFA-CNS 2.6 (1.4) 2 (1.3) 3.4 (1.0) <0.001
SOFA-Liver 0.2 (0.6) 0.2 (0.6) 0.3 (0.6) 0.379
SOFA-coagulation 0.3 (0.7) 0.3 (0.6) 0.4 (0.7) 0.620
SOFA-renal 1 (1.5) 0.7 (1.4) 1.4 (1.6) 0.007
Total SOFA 6.0 (4.3) 3.9 (2.6) 8.5 (4.6) <0.001
Mean SOFA (SD) 6.3 (3.7) 4.7 (2.6) 8.1 (3.9) <0.001
Highest SOFA (SD) 7.5 (4.1) 5.8 (3.2) 9.4 (4.2) <0.001
Delta SOFA (SD) 0.4 (3.2) -1.7 (2.7) 1.0 (3.1) <0.001
SOFA: Sequential organ function assessment; RS: Respiratory system;
CVS: Cardiovascular system; CNS: Central nervous system
Pa values calculated using unpaired t tests, Mann–Whitney U tests
Fig. 2 Association of Initial, Mean and Highest mSOFA with Mortality.
These graphs demonstrate a direct proportionality relationship
between mSOFA scores with mortality even though there was no
significant association in the multivariate analysis. a shows the Initial
mSOFA score association with mortality. b shows the Mean mSOFA
score association with mortality. c shows the highest mSOFA score
association with mortality
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Nepalese study is the only prior study of SOFA scores in
a LIC and utilized the original SOFA score in an urban
hospital (six bed ICU) [12]. That study found significant
predictive value of SOFA scores for mortality using uni-
variate analysis. Similar to our study, Acharya et al. also
had a relatively young patient cohort (mean age 34 years)
with a high mortality rate (40%). Significant differences
between our studies exist and include the relatively
smaller sample size, better hospital resources (e.g. regu-
lar availability of blood gas analyses) and inclusion only
of patients who met the SIRS criteria for the Nepalese
study. Our initial mSOFA was lower than that from
Acharya despite our population having higher mortality
rate overall. This suggests that our SpO2 modification
may underestimate the respiratory variable of the
mSOFA score as discussed in greater detail below.
The results of prior studies of modified SOFA scores
in HICs may not be applicable in LICs due to marked
differences in clinical environments and patient popula-
tions [4, 11]. In the current study we used the SPO2/FiO2
ratio as a surrogate for the PaO2/FiO2 in calculating the
SOFA score, a modification previously validated but only
in HICs [10, 11]. Overall, the PaO2 values were missing in
a very large percentage of our patient despite the fact that
48% had at least one blood gas analysis done during the
ICU stay. This 48% was still a relatively larger proportion
of patients with blood gas done than hypothesized, but
due in large part to a concurrent observational study that
provided cartridges for the blood gas machine stationed in
the ICU. We found that the PaO2 values were missing
even in those who had blood gas analysis done because it
was done outside the recording times: T0 and T48.
Compared to ICUs of HICs, those in LICs have a mor-
tality rate nearly four times higher largely due to inad-
equate resources [1, 2, 4, 12, 16, 19]. The mortality rate
in our study was relatively higher than that found in a
prior study done in the same ICU by Kwizera et al. and
Acharya’s study in Nepal: 47 vs. 43 vs. 40% respectively
[12, 16]. Kwizera et al’s study had no exclusion criteria
unlike our study, which could have led to their slightly
lower mortality rate. The Nepalese study was conducted
in an ICU that was better resourced than our own and
was conducted on patients who met the SIRS criteria.
Since positive SIRS criteria has been associated with a
higher mortality rate [13], it is highly likely that this was
the reason their mortality was nearly as high as that
found in our study.
We found that all patients in the present study had
mSOFA scores more than twice the designated cut off
for organ dysfunction as outlined by the The Third
International Consensus Definitions for Sepsis and
Septic Shock [14]. Similar to other studies, the mSOFA
scores of non-survivors in our cohort were significantly
Fig. 3 Receiver Operating Curves for mSOFA prediction of mortality. The mSOFA demonstrated a poor to fair prediction of mortality. The initial
mSOFA score is represented by Sofatotal1. It showed the lowest predictive power of all categories of the mSOFA. The mSOFA at 48 h, represented
by Sofatotal2, had the highest predictive power followed by the mean, highest and delta mSOFA scores
Table 4 Mortality predictive power of the msofa score for 118
critically ill-patients admitted to mulago hospital icu from
February 2014 to January 2015
mSOFA AUROC 95% Confidence interval
Initial 0.68 0.58–0.78
48 h 0.79 0.71–.88
Mean 0.76 0.68–0.85
Highest 0.76 0.67–0.85
Delta 0.74 0.65–0.84
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higher than those in survivors [5, 7, 8, 12, 19, 20]. We also
found that the initial mSOFA score had the lowest
AUROC compared to the mean, highest and delta mSOFA
scores, similar to prior investigations [8, 12, 21]. With ex-
ception of the initial mSOFA, the other mSOFAs demon-
strated fairly accurate prediction however the confidence
intervals were wide and thus ought to be interpreted with
caution. This was also supported by the finding that the
mean mSOFA had a significantly higher predictability
than the initial mSOFA. Our univariate analysis did show
predictive value for the initial mSOFA yet this relationship
did not hold true with multivariate analysis. Of note, the
prior study in Nepal undertook only univariate analysis
that showed significant associations [12]. Even though we
found no significant association between the mSOFA and
mortality, Fig. 2 shows a linear relationship if a line of best
fit was drawn for each of the mSOFA categories. We still
however, did not find any statistical significance of any of
the slopes in any combination. We believe this was due to
the small sample size such that occurrence of mortality in
any of the ranges we used for each mSOFA category
resulted into a bigger percentage of that category than
would have been otherwise.
Prior studies have found that SOFA score is most pre-
dictive in the first 48 h and can be used to assess degree
of organ dysfunction, mortality and response to therapy
throughout admission [8]. Although our results were un-
able to corroborate all of these findings, this study pro-
vides evidence that further validation and modification
of the most recent sepsis definitions is feasible in LICs
and warranted. The utility of a simple validated tool for
assessing and predicting outcomes in LICs would have
far-reaching applicability that extends beyond patient
care and also includes future research to improve out-
comes in these settings.
There were several limitations with the present study.
The first and most significant was low power due to small
sample size. Due to limited access to medical records and
limited study personnel, we were unable to enroll and
analyze data for patients admitted for less than 24 h. This
resulted in the exclusion of a large number of potential
study subjects. Another significant limitation of the current
study may be attributable to the modification of SOFA
scores using SpO2 in our setting. There are several reasons
the SpO2/FiO2 calculation may not accurately reflect sever-
ity of pulmonary dysfunction. For example, in order to be
categorized in the sickest mSOFA cohort by SpO2, a pa-
tient would need to have a SpO2 of <67% while on 100%
FiO2. Only three patients in our cohort met this criterion.
Our use of SpO2 likely underestimated severity of pulmon-
ary dysfunction. For example, a patient with an SpO2 of
90% on 100% FiO2 would be given 3 points using the
mSOFA (90/1 = 90; Table 3). Using the original SOFA
score and assuming that same patient has a PaO2 of ~60,
the patient would be given 4 points (60/1 = 60; Table 3). An
additional significant limitation of SpO2/FiO2 calculations
in our setting is the lack of reliable oxygen sources. For ex-
ample, tank and wall oxygen frequently are less than 100%
FiO2 (anecdotally as low as 70%). This could result in sig-
nificant overestimation of severity of pulmonary dysfunc-
tion. In future investigations, the investigation of multiple
SpO2 respiratory thresholds may yield improved predictive
value for the mSOFA Score. An additional limitation that
we must recognize due to our single site design is the pos-
sibility for site bias. We performed the mSOFA score on
only two occasions, 48 h apart, limiting the information on
organ dysfunction assessment over the length of stay with
treatment. The generalizability to austere environments
outside our study setting is challenging, as further investi-
gation and more robust study resources are needed.
Conclusion
Our results confirm that calculation of the mSOFA score
is feasible for an ICU population in a low-income coun-
try. Although the present study did not demonstrate a
definitive relation between mSOFA and mortality, larger
studies are needed to assess the discriminative power of
mSOFA for predicting organ dysfunction and mortality
in resource-limited settings. Such data may be able to
help better characterize critical illness disease burden
and the triage of limited resources.
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